Hyperekplexia: A Chinese Adolescent With 2 Novel Mutations of the GLRA1 Gene

Hyperekplexia is a rare neurologic disorder, characterized by excessive startle response to unexpected stimuli. There are 3 cardinal features: generalized stiffness immediately after birth that normalizes during the first year of life; excessive startle reflex to unexpected (particularly auditory) stimuli; and a short period of generalized stiffness following the startle response while patient cannot elicit voluntary movements. Awareness of this condition will avoid misdiagnosis of disorders like epilepsy. Clonazepam is an effective medical treatment. We report a patient whose frequent falls triggered by sudden noise or tactile stimuli was initially misdiagnosed as epilepsy. The clinical diagnosis was subsequently revised to hyperekplexia and confirmed by mutation analysis of the GLRA1 gene, which showed c.497G>C (p.Cys166Ser) and c.526delG (p.Asp176Metfs*16). Both of them are novel mutations. His response to clonazepam is dramatic and has been able to engage in sports and social activities.

[1]  M. Topf,et al.  Mutations in the GlyT2 Gene (SLC6A5) Are a Second Major Cause of Startle Disease* , 2012, The Journal of Biological Chemistry.

[2]  S. Ellard,et al.  Using SIFT and PolyPhen to predict loss-of-function and gain-of-function mutations. , 2010, Genetic testing and molecular biomarkers.

[3]  M. Tijssen,et al.  Startle syndromes , 2009 .

[4]  M. Owen,et al.  The GDP-GTP Exchange Factor Collybistin: An Essential Determinant of Neuronal Gephyrin Clustering , 2004, The Journal of Neuroscience.

[5]  M. Owen,et al.  Isoform Heterogeneity of the Human Gephyrin Gene (GPHN), Binding Domains to the Glycine Receptor, and Mutation Analysis in Hyperekplexia* , 2003, Journal of Biological Chemistry.

[6]  C. Becker,et al.  The Inhibitory Glycine Receptor - Simple Views of a Complicated Channel , 2003 .

[7]  C. Becker,et al.  The Inhibitory Glycine Receptor—Simple Views of a Complicated Channel , 2002, Chembiochem : a European journal of chemical biology.

[8]  M. Owen,et al.  Hyperekplexia associated with compound heterozygote mutations in the beta-subunit of the human inhibitory glycine receptor (GLRB). , 2002, Human molecular genetics.

[9]  S. Patole,et al.  Hyperekplexia in neonates , 2001, Postgraduate medical journal.

[10]  M. Owen,et al.  Compound heterozygosity and nonsense mutations in the α1-subunit of the inhibitory glycine receptor in hyperekplexia , 2001, Human Genetics.

[11]  A. Poustka,et al.  The human glycine receptor beta subunit gene (GLRB): structure, refined chromosomal localization, and population polymorphism. , 1998, Genomics.

[12]  R. Ophoff,et al.  Hyperekplexia-like syndromes without mutations in the GLRA1 gene , 1997, Clinical Neurology and Neurosurgery.

[13]  M. Nigro,et al.  Hyperekplexia and sudden neonatal death. , 1992, Pediatric neurology.

[14]  B. Bernardina,et al.  STARTLE DISEASE: AN AVOIDABLE CAUSE OF SUDDEN INFANT DEATH , 1989, The Lancet.

[15]  F. Andermann,et al.  Startle disease, or hyperekplexia , 1984, Annals of neurology.

[16]  M. Owen,et al.  Mutations in the gene encoding GlyT2 (SLC6A5) define a presynaptic component of human startle disease , 2006, Nature Genetics.